Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to evaluate the feasibility defined as overall tolerance and toxicity as well as relative dose-intensity and cumulative dose delivered, of an association ofgemcitabine, oxaliplatin and radiotherapy in patients with locally advanced and unresectable, but non-metastatic pancreatic adenocarcinoma or cholangiocarcinoma


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Cholangiocarcinoma
  • Locally Advanced and Unresectable, But Non-metastatic Pancreatic Adenocarcinoma or Cholangiocarcinoma

NCT number NCT00286013
Study type Interventional
Source University Hospital, Ghent
Contact
Status Completed
Phase Phase 2
Start date May 1, 2004
Completion date July 22, 2008